Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Health In Tech, Inc.HIT · Entity 7078 | Director | October 07, 2026 | October 09, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Health In Tech, Inc.
Report date October 07, 2026 · Filed October 09, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 164,811 |
Reported balance
After 2026-10-07 transaction · row 1
1 source rowRow 1 · 2026-10-07 · Grant · Acquired 26,301 · Balance 164,811 F1: Represents restricted shares of Class A Common Stock granted to the reporting person pursuant to the Health in Tech Equity Incentive Plan. The shares of restricted stock vested as of their grant date. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents restricted shares of Class A Common Stock granted to the reporting person pursuant to the Health in Tech Equity Incentive Plan. The shares of restricted stock vested as of their grant date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 07, 2026 Filed Oct 9, 2026 20:30 UTC | Health In Tech, Inc. HIT · Entity 7078 | GrantClass A Common Stock | 26,301 | $0.76 | $19,988.76 |
DisclosureSEC source: 0001213900-26-108500 · ownership.xml · nonDerivative · entry 1 Howard William D. · CIK 0001993318 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 164,811 F1 · shares: Represents restricted shares of Class A Common Stock granted to the reporting person pursuant to the Health in Tech Equity Incentive Plan. The shares of restricted stock vested as of their grant date. Read SEC document |
| July 08, 2026 Filed Jul 10, 2026 22:46 UTC | Health In Tech, Inc. HIT · Entity 7078 | GrantClass A Common Stock | 18,867 | $1.06 | $19,999.02 |
DisclosureSEC source: 0001213900-26-077302 · ownership.xml · nonDerivative · entry 1 Howard William D. · CIK 0001993318 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 138,510 F1 · shares: Represents restricted shares of Class A Common Stock granted to the reporting person pursuant to the Health in Tech Equity Incentive Plan. The shares of restricted stock vested as of their grant date. Read SEC document |
| April 08, 2026 Filed Apr 11, 2026 00:42 UTC | Health In Tech, Inc. HIT · Entity 7078 | GrantClass A Common Stock | 13,598 | $1.36 | $18,493.28 |
DisclosureSEC source: 0001213900-26-042697 · ownership.xml · nonDerivative · entry 1 Howard William D. · CIK 0001993318 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 119,643 F1 · shares: Represents restricted shares of Class A Common Stock granted to the reporting person pursuant to the Health in Tech Equity Incentive Plan. The shares of restricted stock vested as of their grant date. Read SEC document |
| October 08, 2025 Filed Oct 10, 2025 21:22 UTC | Health In Tech, Inc. HIT · Entity 7078 | GrantClass A Common Stock | 5,730 | $3.49 | $19,997.70 |
DisclosureSEC source: 0001213900-25-098194 · ownership.xml · nonDerivative · entry 2 Howard William D. · CIK 0001993318 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 106,045 F2 · shares: Represent restricted shares of Class A Common Stock granted to the reporting person pursuant to the Health in Tech Equity Incentive Plan. The shares of restricted stock vest quarterly commencing upon the date of grant, subject to the reporting person's continuous service through the vesting date. F3 · balance_after: Includes 5,730 shares of restricted stock and 100,315 shares of Class A Common Stock. Read SEC document |
| October 03, 2025 Filed Oct 10, 2025 21:22 UTC | Health In Tech, Inc. HIT · Entity 7078 | Disposition to issuerClass A Common Stock | 28,159 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-25-098194 · ownership.xml · nonDerivative · entry 1 Howard William D. · CIK 0001993318 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,315 F1 · shares: Represent restricted shares of Class A Common Stock granted to the reporting person pursuant to the Health in Tech Equity Incentive Plan, which were subject to forfeiture on a pro-rata basis upon the issuer's annual stockholders meeting held on October 3, 2025. Read SEC document |
| June 23, 2025 Filed Jun 26, 2025 01:00 UTC | Health In Tech, Inc. HIT · Entity 7078 | GrantClass A Common Stock | 128,474 | $0.62 | $79,653.88 |
DisclosureSEC source: 0001213900-25-057986 · ownership.xml · nonDerivative · entry 1 Howard William D. · CIK 0001993318 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 128,474 F1 · shares: Represent restricted shares of Class A Common Stock granted to the reporting person pursuant to the Health in Tech Equity Incentive Plan. The shares of restricted stock vest either (i) fully upon one year of service commencing on December 23, 2024, or (ii), if not vested upon such date, partially vest at the first shareholders' meeting, with the number of vested shares determined by multiplying the total number of restricted stock by a ratio with the numerator being the lesser of the period of time since December 23, 2024 and 12 months and the denominator being 12 months, subject to the reporting person's continuous service through the vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.